Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Change in Inventory: 2024

Historic Change in Inventory for Madrigal Pharmaceuticals (MDGL) over the last 1 years, with Dec 2024 value amounting to $34.1 million.

  • Madrigal Pharmaceuticals' Change in Inventory rose 254.23% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.6 million, marking a year-over-year change of. This contributed to the annual value of $34.1 million for FY2024, which is N/A change from last year.
  • Per Madrigal Pharmaceuticals' latest filing, its Change in Inventory stood at $34.1 million for FY2024.
  • Over the past 5 years, Madrigal Pharmaceuticals' Change in Inventory peaked at $34.1 million during FY2024, and registered a low of $34.1 million during FY2024.
  • Its 1-year average for Change in Inventory is $34.1 million, with a median of $34.1 million in 2024.